Robert Makowsky1, Pema Lhaki2, Howard W Wiener3, Madhav P Bhatta4, Michael Cullen5, Derek C Johnson3, Rodney T Perry3, Mingma Lama2, Joseph F Boland5, Meredith Yeager5, Sarita Ghimire6, Thomas R Broker7, Sadeep Shrestha8. 1. Department of Biostatistics, School of Public Health, University of Alabama at Birmingham, AL, USA. 2. NFCC International, Kathmandu, Nepal. 3. Department of Epidemiology, School of Public Health, University of Alabama at Birmingham, AL, USA. 4. Department of Biostatistics, Environmental Health Sciences, and Epidemiology, College of Public Health, Kent State University, OH, USA. 5. Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD, USA; Cancer Genomics Research Laboratory, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research Inc., Gaithersburg, MD, USA. 6. Cancer Screening Center, Nepal Cancer Care Foundation, Lalitpur, Nepal. 7. Department of Biochemistry and Molecular Genetics, University of Alabama at Birmingham, Birmingham, AL, USA. 8. Department of Epidemiology, School of Public Health, University of Alabama at Birmingham, AL, USA. Electronic address: sshrestha@uab.edu.
Abstract
OBJECTIVES/ BACKGROUND: Sequence variants in HPV16 confer differences in oncogenic potential; however, to date there have not been any HPV sequence studies performed in Nepal. The objective of this study was to characterize HPV16 viral genome sequences from Nepal compared to a reference sequence in order to determine their lineages. Additionally, we sought to determine if five High-grade Squamous Intraepithelial Lesion (HSIL) subjects were genetically distinct from the non-HSIL subjects. METHODS: DNA was isolated from exfoliated cervical cells from 17 individuals in Nepal who were previously identified to be HPV16-positive. A custom HPV16 Ion Ampliseq panel of multiplexed degenerate primers was designed that generated 47 overlapping amplicons and covered 99% of the viral genome for all known HPV16 variant lineages. All sequence data were processed through a custom quality control and analysis pipeline of sequence comparisons and phylogenetic analysis. RESULTS: There were high similarities across the genomes, with two major indels observed in the non-coding region between E5 and L2. Compared to the PAVE reference HPV16 genome, there were up to 9, 4, 38, 27, 8, 7, 52, and 32 nucleotide variants in the E6, E7, E1, E2, E4, E5, L2, and L1 genes in the Nepalese samples, respectively. Based on sequence variation, HPV16 from Nepal falls across the A, C, and D lineages in this study. We found no evidence of genetic distinctness between HSIL and non-HSIL subjects. CONCLUSIONS: The evolutionary and pathological characteristics of the representative HPV16 genomes from Nepal seem similar to results from other parts of the world and provide the basis for further studies. Copyright Â
OBJECTIVES/ BACKGROUND: Sequence variants in HPV16 confer differences in oncogenic potential; however, to date there have not been any HPV sequence studies performed in Nepal. The objective of this study was to characterize HPV16 viral genome sequences from Nepal compared to a reference sequence in order to determine their lineages. Additionally, we sought to determine if five High-grade Squamous Intraepithelial Lesion (HSIL) subjects were genetically distinct from the non-HSIL subjects. METHODS: DNA was isolated from exfoliated cervical cells from 17 individuals in Nepal who were previously identified to be HPV16-positive. A custom HPV16 Ion Ampliseq panel of multiplexed degenerate primers was designed that generated 47 overlapping amplicons and covered 99% of the viral genome for all known HPV16 variant lineages. All sequence data were processed through a custom quality control and analysis pipeline of sequence comparisons and phylogenetic analysis. RESULTS: There were high similarities across the genomes, with two major indels observed in the non-coding region between E5 and L2. Compared to the PAVE reference HPV16 genome, there were up to 9, 4, 38, 27, 8, 7, 52, and 32 nucleotide variants in the E6, E7, E1, E2, E4, E5, L2, and L1 genes in the Nepalese samples, respectively. Based on sequence variation, HPV16 from Nepal falls across the A, C, and D lineages in this study. We found no evidence of genetic distinctness between HSIL and non-HSIL subjects. CONCLUSIONS: The evolutionary and pathological characteristics of the representative HPV16 genomes from Nepal seem similar to results from other parts of the world and provide the basis for further studies. Copyright Â
Authors: Mark Schiffman; Ana Cecilia Rodriguez; Zigui Chen; Sholom Wacholder; Rolando Herrero; Allan Hildesheim; Rob Desalle; Brian Befano; Kai Yu; Mahboobeh Safaeian; Mark E Sherman; Jorge Morales; Diego Guillen; Mario Alfaro; Martha Hutchinson; Diane Solomon; Philip E Castle; Robert D Burk Journal: Cancer Res Date: 2010-03-30 Impact factor: 12.701
Authors: Narayanan Sathish; Priya Abraham; Abraham Peedicayil; Gopalan Sridharan; George Chandy Journal: Cancer Lett Date: 2005-11-08 Impact factor: 8.679
Authors: Laura Sichero; Silvaneide Ferreira; Helen Trottier; Eliane Duarte-Franco; Alex Ferenczy; Eduardo Luis Franco; Luisa Lina Villa Journal: Int J Cancer Date: 2007-04-15 Impact factor: 7.396
Authors: Lisa Mirabello; Meredith Yeager; Michael Cullen; Joseph F Boland; Zigui Chen; Nicolas Wentzensen; Xijun Zhang; Kai Yu; Qi Yang; Jason Mitchell; David Roberson; Sara Bass; Yanzi Xiao; Laurie Burdett; Tina Raine-Bennett; Thomas Lorey; Philip E Castle; Robert D Burk; Mark Schiffman Journal: J Natl Cancer Inst Date: 2016-04-29 Impact factor: 13.506
Authors: Derek C Johnson; Madhav P Bhatta; Jennifer S Smith; Mirjam-Colette Kempf; Thomas R Broker; Sten H Vermund; Eric Chamot; Shilu Aryal; Pema Lhaki; Sadeep Shrestha Journal: PLoS One Date: 2014-06-30 Impact factor: 3.240
Authors: Philipp Schwabl; Jalil Maiguashca Sánchez; Jaime A Costales; Sofía Ocaña-Mayorga; Maikell Segovia; Hernán J Carrasco; Carolina Hernández; Juan David Ramírez; Michael D Lewis; Mario J Grijalva; Martin S Llewellyn Journal: PLoS Genet Date: 2020-12-16 Impact factor: 5.917